Enzyme May Be Key to Unlocking Treatment for Cancer, Diabetes, College of Pharmacy Researcher Says

News Release Date: 
Tuesday, September 22, 2020

Preliminary studies conducted by James Galligan, PhD, an assistant professor at the University of Arizona College of Pharmacy, suggest the enzyme glyoxalase II (GLO2) is a strong candidate for drug developers to consider as a potential treatment for breast cancer and diabetes.

Read more here

Event Date: 
Tuesday, September 22, 2020 (All day)